Encouraging Signs For Galapagos In CLL, But “Point-Of-Care CAR-T” Is Biggest Challenge

Early data suggests its CAR-T could crack the tough challenge in CLL – but developing an automated CAR-T production unit for local hospitals is likely to be Galapagos’s greatest test.

Cocoon
Galapagos is developing its point-of-care 'Cocoon' manufacturing system to bring CAR-T to many more patients globally.

More from Clinical Trials

More from R&D